UBS Global Research on Tuesday raised its year-end target for the benchmark S&P 500 index to 5,850 points from an earlier ...

AbbVie has been reporting an earnings decline because its former lead drug, Humira, lost patent-protected market exclusivity ...

One chief equity strategist says that the S&P 500 Index could face a significant decline next year following its 2024 gains.

The S&P 500 advanced 0.8% on Monday, adding to the benchmark index's all-time high Friday for a second straight record close.

One of the primary goals of investing money is to eventually take out more than you put in—buy low and sell high. But has ...

MicroStrategy stock has outperformed all S&P 500 firms since 2020, but despite its robust performance, a listing in the index ...

The S&P 500 index was up slightly Wednesday, with sector gains led by utilities and financials, according to FactSet data, at last check. The utilities sector was up 1.1% Wednesday morning, while the ...

Short interest for healthcare stocks in S&P 500 increased during September end vs. last month, with Moderna being most ...

The S&P 500 may be punching through fresh records, but it hasn’t been accompanied by high turnover conviction. On the ...

The S&P 500’s information-technology sector was dropping sharply heading toward the closing bell on Tuesday, dragging down the U.S. equities benchmark. Technology was slumping 2%, according to FactSet ...

The S&P 500 finished the week ending October 11 with another record-breaking rally, up 0.97% from last Friday.

Wall Street strategists are rushing to ratchet up their US stock-market forecasts as equities stage the strongest rally in ...